BAE Systems Announces 2025 Full Year Results February 23, 2026 Charles Woodburn, Chief Executive, said: “Our results highlight another year of strong operational and financial performance, thanks to the outstanding dedication of our employees. In a new era of defence spending, driven by escalating security challenges, we’re well positioned to provide both the advanced conventional systems and disruptive technologies needed to protect the nations we [...]
Toshiba Showcases End-to-End Innovations Shaping What’s Next in Retail at EuroShop 2026 February 23, 2026 At EuroShop, Toshiba showcases intelligent, scalable solutions that combine AI, computer vision, and energy-efficient design to transform the future of retail.
Graphene Launches Authorised Investment Platform for Alpha Investment Office February 23, 2026 Platform delivers regulated infrastructure, custody connectivity and end-to-end investment operations to support Alpha’s growth strategy
Almirall’s 2025 Results February 23, 2026 Almirall meets guidance for 2025, delivering 12.4% net sales growth and further pipeline progress, continuing its sustained growth trajectory with strong dermatology performance and commercial execution in Europe Almirall delivered net sales growth in 2025 of 12.4% exceeding €1bn (total of €1,108.1MM), revenue increase of 12.5% (total of €1,114.5 MM), and EBITDA growth of 20.9% (total of €232.9 MM) – in line with its guidance and its sustained growth trajectory. This revenue growth further advances Almirall’s leadership in medical dermatology driven by the strong performance of its European dermatology business (+25.6% YoY increase to a total of €608 MM). The continued strong performance of the biologics portfolio is the backbone of Almirall’s growth, with Ilumetri® net sales increasing 12.3% YoY (total of €234.4 MM), and Ebglyss® net sales increasing more than 3x YoY to a total of €110.8 MM – reflecting its strong position and growth trajectory across Europe in the second year after launch. Continued solid performance of the broad dermatology product portfolio with Wynzora® growing 30.5% YoY to a total of €33.8 MM, and Klisyri® growing 33.9% YoY to a total of €32.8 MM, further enhances Almirall’s position as trusted partner for patients and dermatologists. Almirall’s business performance fuels the advancement of a diversified and innovative R&D pipeline addressing skin diseases with high unmet need. Pipeline progress in 2025 included the start of the phase II study of the anti-IL-1RAP mAb in Hidradenitis suppurativa, the start of the phase II study of the IL-2muFc in Alopecia areata, and the approval of Jublia® in Germany and Seysara® in China. Guidance for 2026: net sales growth of 9%-12% and total EBITDA between €270 MM and €290 MM.
AHS Tower Fully Sold During Development, Generating More Than USD 700 Million February 23, 2026 A new commercial landmark on Sheikh Zayed Road underscores market momentum for next-generation workspaces in Dubai.
INCERGO S.A. Announces Share Capital Increase and Strategic Shareholding with Visual Semiconductor February 23, 2026 INCERGO S.A. (Symbol: ICG) announces that, effective February 19, 2026, its issued share capital has increased from 5,060,000 to 151,283,387 registered ordinary shares. The issuance of 146,223,387 new shares has been duly registered and is effective on the Vienna Stock Exchange as of today. The company announced further progress in its merger with Visual Semiconductor [...]
How to solve the energy crisis? Give power back to the markets February 23, 2026 Solving the energy crisis needs the dynamism of the private sector, not more government subsidies and central planning, writes Emma Revell.
Bank to business lending growth to halve amid global tensions February 23, 2026 UK bank to businesses lending growth is forecast to halve this year as firms feel the pinch of challenging conditions amid global tensions. Net growth in the value of lending from the banking sector to businesses is tipped to slow to 3.5 per cent this year, standing at nearly half of the 6.9 per cent [...]
‘Drastic’ Dave to serve up new vision for Guinness maker Diageo February 22, 2026 It’s been a rocky 12 months for drinks titan Diageo and Sir Dave Lewis will be looking to cure the firm’s long-running hangover when he serves up his future vision next week. Diageo’s stock has tumbled over 15 per cent in the last 12 months with a notable drop in November after operating profit growth [...]
Trump says he is raising global tariffs after Supreme Court ruling February 21, 2026 US President Donald Trump has said he will raise his new global tariff rate to 15 per cent from 10 per cent, a day after the US Supreme Court struck down his policy. Trump signed a proclamation slapping a temporary 10 per cent duty on imports under section 122 of the 1974 trade act, which [...]